Distribuzione geografica
Continente #
NA - Nord America 8952
EU - Europa 4858
AS - Asia 210
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
OC - Oceania 1
Totale 14048
Nazione #
US - Stati Uniti d'America 8934
PL - Polonia 1942
IE - Irlanda 862
SE - Svezia 619
IT - Italia 477
UA - Ucraina 323
DE - Germania 221
FI - Finlandia 209
CN - Cina 105
GB - Regno Unito 88
TR - Turchia 49
VN - Vietnam 36
FR - Francia 28
RU - Federazione Russa 25
AT - Austria 23
SC - Seychelles 17
CA - Canada 16
BE - Belgio 15
IN - India 12
NL - Olanda 9
ES - Italia 4
RO - Romania 4
CH - Svizzera 3
EU - Europa 3
IR - Iran 3
MM - Myanmar 3
BA - Bosnia-Erzegovina 2
BR - Brasile 2
BY - Bielorussia 2
GR - Grecia 2
MU - Mauritius 2
MX - Messico 2
PH - Filippine 2
AU - Australia 1
EG - Egitto 1
PE - Perù 1
TN - Tunisia 1
Totale 14048
Città #
Warsaw 1942
Fairfield 1699
Chandler 883
Dublin 862
Woodbridge 751
Seattle 730
Cambridge 709
Ashburn 708
Wilmington 596
Houston 581
Jacksonville 542
Ann Arbor 269
Princeton 246
Altamura 201
Lawrence 191
Boston 134
Medford 118
Buffalo 115
Boardman 103
San Diego 98
Beijing 91
Florence 90
Izmir 45
Norwalk 41
Dong Ket 32
Falls Church 32
Andover 28
Vienna 23
Milan 20
Frankfurt Am Main 17
Brussels 15
Auburn Hills 13
Phoenix 13
Dearborn 12
Toronto 11
Rome 10
Verona 10
Los Angeles 9
Bremen 7
Old Bridge 7
Detroit 6
Laurel 6
Saint Petersburg 6
Redwood City 5
Barcelona 4
Fuzhou 4
Redmond 4
Chicago 3
Deiva Marina 3
Munich 3
Ottawa 3
San Mateo 3
Siena 3
Torino 3
Yangon 3
Abbotsford 2
Arezzo 2
Augusta 2
Bennekom 2
Focşani 2
Gioia Del Colle 2
Grugliasco 2
Hanover 2
Hefei 2
Iasi 2
Larissa 2
Leawood 2
Livorno 2
Naaldwijk 2
Sarajevo 2
Ankara 1
Balıkesir 1
Basel 1
Bristol 1
Cedar Knolls 1
Centrale 1
Centro 1
Chongqing 1
Circleville 1
Dallas 1
Düsseldorf 1
Grevenbroich 1
Harbin 1
Hebei 1
Incisa 1
Jinan 1
Kunming 1
Ladispoli 1
Lima 1
Lucca 1
Mcallen 1
Melbourne 1
Mumbai 1
Nanjing 1
Napoli 1
Nocera Superiore 1
Pavia 1
Perugia 1
Pindamonhangaba 1
Pisa 1
Totale 12123
Nome #
Adipokines as possible new predictors of cardiovascular diseases: a case control study. 244
Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study). 235
Sustained Exendin-4 Secretion through Gene Therapy Targeting Salivary Glands in Two Different Rodent Models of Obesity/Type 2 Diabetes. 218
Role of endothelin-1 in the migration of human olfactory gonadotropin-releasing hormone-secreting neuroblasts. 210
Present and future association between obesity and hypogonadism in Italian male 209
Metformin and cancer occurrence in insulin-treated type 2 diabetic patients. 205
Inflammatory mediators, obesity and type 2 diabetes stimulate adhesion of human dendritic cells to coronary smooth muscle cells. 200
Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes 199
Clinical and psychological correlates of health-related quality of life in obese patients. 198
Fit and motivated: outcome predictors in patients starting a program for lifestyle change. 195
The role of DPP4 activity in cardiovascular districts: in vivo and in vitro evidence. 193
Inflammatory molecules affect the interaction between human dendritic cells and vascular smooth muscle cells 153
False and true pre-treatment predictors of weight loss in obese patients starting a program for lifestyle change. 144
Potential Role for Dendritic Cells in Endothelial Dysfunction, Diabetes and Cardiovascular Disease 137
The therapy of insulin resistance in other diseases besides type 2 diabetes. 134
Expression and function of gonadotropin-releasing hormone (GnRH) receptor in human olfactory GnRH-secreting neurons: an autocrine GnRH loop underlies neuronal migration. 121
A case of malignant insulinoma responsive to somatostatin analogs treatment 114
Platelet-activating factor enhances production of insulin-like growth factor binding proteins in a human adenocarcinoma cell line (HEC-1A) 112
Lipoperoxidation and antioxidant capacity in patients with poorly controlled type 2 diabetes. 104
Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells. 98
Characterization of circulating and monocyte-derived dendritic cells in obese and diabetic patients 97
Italian toasted bread ('bruschetta') should be carefully evaluated by people with type 1 diabetes. 97
Hypertriglyceridaemic waist phenotype and β-cell function in subjects with normal and impaired glucose tolerance. 94
Is obesity a further cardiovascular risk factor in patients with erectile dysfunction? 93
Assessment of psychological predictors of weight loss: How and what for? 92
5-HT2A receptor gene polymorphism and eating disorders. 91
Intermittent high glucose concentrations reduce neuronal precursor survival by altering the IGF system: the involvement of the neuroprotective factor DHCR24 (Seladin-1) 91
Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions. 90
From theory to clinical practice in the use of GLP-1 receptor agonists and DPP-4 inhibitors therapy. 89
Comparison of individual and group cognitive behavioral therapy for binge eating disorder. A randomized, three-year follow-up study. 88
Oxidative DNA damage in peripheral blood cells in type 2 diabetes mellitus: higher vulnerability of polymorphonuclear leukocytes 85
Loss of adrenergic regulation of cAMP production in the FRTL-5 cell line. 85
Parathyroid hormone bioassay using human kidney cortical cells in primary culture. 84
Lower and higher-potency statins on glycemic control in type 2 diabetes: A retrospective cohort study 84
Acetaldehyde induces c-fos and c-jun proto-oncogenes in fat-storing cell cultures through protein kinase C activation 80
Insulin stimulates cell growth of a new strain of differentiated rat thyroid cells. 80
Case-control and combined family trios analysis of three polymorphisms in the ghrelin gene in European patients with anorexia and bulimia nervosa. 80
Correlations between binge eating and emotional eating in a sample of overweight subjects 79
Different moderators of cognitive-behavioral therapy on subjective and objective binge eating in bulimia nervosa and binge eating disorder: a three-year follow-up study. 79
Variability of triglyceride levels and incidence of microalbuminuria in type 2 diabetes 79
Catecholamine, vasoactive intestinal peptide and thyrotrophin-dependent cAMP levels display a different sensitivity to iodothyronines in both normal and pathological human thyroid cells in culture. 78
Sexual Function in Obese Women with and without Binge EatingDisorder. 78
Measurement of body composition as a surrogate evaluation of energy balance in obese patients. 78
5-HT2A promoter polymorphism in anorexia nervosa. 78
Salmon calcitonin and cGMP production by human kidney: studies in vivo and in vitro. 78
Cholinergic control of cyclic nucleotide metabolism in human thyroid cells. 77
Effect of prostaglandin E2 on adenylate cyclase system in human kidney cell cultures: interactions with parathormone and arginine-vasopressin. 76
Vitamin D therapy in adults with diabetes mellitus. 76
Acetaldehyde-protein adducts, but not lactate and pyruvate, stimulate gene transcription of collagen and fibronectin in hepatic fat-storing cells 76
Studies of catecholamine effect on cyclic AMP in human cultured thyroid cells: their interaction with thyrotrophin receptor. 76
Regulatory role of eicosanoids in extracellular matrix overproduction induced by long-term exposure to high glucose in cultured rat mesangial cells. 75
Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients. 75
Low adherence of a clinically healthy Italian population to nutritional recommendations for primary prevention of chronic diseases 75
Human calcitonin increases both cyclic AMP and cyclic GMP accumulation in human kidney cells. 75
Forskolin perturbs cGMP as well as cAMP levels in human thyroid cells. 75
Glucocorticoid receptor gene polymorphisms in Italian patients with eating disorders and obesity. 74
Sex steroids and odorants modulate gonadotropin-releasing hormone secretion in primary cultures of human olfactory cells. 73
Insulin-like growth factor-I: autocrine secretion by human thyroid follicular cells in primary culture. 73
Adherence to structured physical exercise in overweight and obese subjects: A review of psychological models 73
Eating disorders in patients with type 1 diabetes: a meta-analysis. 72
Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes 72
Lipid levels in obese and nonobese subjects as predictors of fasting and postload glucose metabolism. 71
Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study. 70
Screening for Binge Eating Disorder in obese outpatients. 70
Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells 70
The diabetic cardiomyopathy. 70
Psychopathological traits and 5-HT2A receptor promoter polymorphism (-1438 G/A) in patients suffering from Anorexia Nervosa and Bulimia Nervosa. 70
Glucagon-like Peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus. 69
Diabetic microangiopathy: IGFBP control endothelial cell growth by a common mechanism in spite of their species specificity and tissue peculiarity. 69
Group versus individual cognitive-behavioral treatment for obesity: Results after 36 months 69
Inflammation markers and metabolic characteristics of subjects with 1-h plasma glucose levels. 67
Comparison between 2 insulin sensitivity indexes in obese patients 67
Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance. 66
Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus. 66
Failure to metformin and insulin secretagogue monotherapy: an observational cohort study. 66
Motivational readiness for treatment in weight control programs: the treatment motivation and readiness (tre-more) test 66
The relationship of growth and adenylate cyclase activity in cultured thyroid cells: separate bioeffects of thyrotropin. 66
A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients 66
Effect of lower diagnostic thresholds on estimates of prevalence of impaired fasting glucose (IFG). 65
Aggressiveness, Anger and Eating Disorders: a Review. 65
Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients. 65
Amphetamine derivatives and obesity 65
Motivational enhancement therapy in obese patients: A promising application 65
Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control 65
Plasma adiponectin and hyperglycaemia in diabetic patients 65
Diagnostic Crossover and Outcome Predictors in Eating Disorders According to DSM-IV and DSM-V Proposed Criteria: A 6-Year Follow-Up Study. 65
The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice. 65
Dendritic cell phenotype and function are modulated by inflammation and insulin-resistance. 65
Different distribution of phenotypes and glucose tolerance categories associated with two alternative proposed cutoffs of insulin resistance. 65
Time to insulin in type-2 diabetes: high hurdles or Santiago way? 64
5-HT2A receptor gene polymorphisms in anorexia nervosa and bulimia nervosa 64
Correlation between HDL cholesterol levels and beta-cell function in subjects with various degree of glucose tolerance. 64
Comparison of ADA and WHO screening methods for diabetes Mellitus in obese patients. 63
Comparison among different insulin sensitivity indices in obese patients 63
Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort study. 63
Eating disorders and body image disturbances among ballet dancers, gymnasium users and body builders. 63
Determinants of testosterone recovery after bariatric surgery: is it only a matter of reduction of body mass index? 63
Relationship between leptin and oestrogens in healthy women 63
Effect of Metformin on Glucagon-Like Peptide 1 (GLP-1) and Leptin levels in obese nondiabetic subjects. 63
Totale 9322
Categoria #
all - tutte 21315
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21315

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018505 0000 00 6634 11410512759
2018/20192330 63416536 16241 7532 63352748652
2019/20203868 34529395345 423490 418492 38322328873
2020/20212168 213158205190 79286 74191 191276123182
2021/20221419 431219366 5959 5285 8453287417
2022/20232991 400605117340 266738 5250 0000
Totale 14163